Wells Fargo’s Neuraxis NRXS Stock Holding History

Wells Fargo’s Portfolio NRXS Stock Details NRXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7	Closed	-$22	–	7280
2024 Q1	$22	Sell	7 -1	-13%	-$3	﹤0.01%	7084
2023 Q4	$21	Hold	8	–	–	﹤0.01%	7203
2023 Q3	$30	Buy	+8	New	+$37	﹤0.01%	7067

Other funds holding NRXS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo's NRXS Position: Q2 2024 in Review

Wells Fargo sold out of Neuraxis (NRXS) in Q2 2024, closing a stake of 7 shares — an estimated $22 sold.

Wells Fargo first reported a position in NRXS in Q3 2023 and held it in 3 quarters. The position peaked at $30 in Q3 2023. 10 funds tracked by Wall St. Rank hold NRXS as of Q2 2024.

Wells Fargo reported no remaining Neuraxis position as of Q2 2024 after selling out during the quarter.
Wells Fargo sold 7 Neuraxis shares in Q2 2024, an estimated $22.
Wells Fargo first reported a position in Neuraxis in Q3 2023 and held it in 3 quarters.
Wells Fargo's Neuraxis position peaked at $30 in Q3 2023.
10 funds tracked by Wall St. Rank held Neuraxis as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.